|
|
|
|
| LEADER |
03364nam a22003015i 4500 |
| 001 |
000280241 |
| 005 |
20210624133928.0 |
| 007 |
cr nn 008mamaa |
| 008 |
161020s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319430997
|
| 024 |
7 |
|
|a 10.1007/978-3-319-43099-7
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Developing Drug Products in an Aging Society :
|b From Concept to Prescribing /
|c edited by Sven Stegemann.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XVIII, 771 p. 96 illus., 85 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a AAPS Advances in the Pharmaceutical Sciences Series,
|v 24
|
| 505 |
0 |
|
|a Healthcare provision in an aging society: US perspective -- Healthcare provision in an aging society: European perspective -- Healthcare provision in an aging society: Japanese perspective -- Old, Very Old, and Frail -- Age and the process of aging -- Comprehensive Geriatric Assessment -- Patients' clinical characteristics, disease, experience, and perception -- Ethical considerations in performing clinical trials in and for older people -- Patient reported outcomes from a clinical to a therapeutic tool -- Pharmacokinetic and Pharmacodynamic Considerations in the Elderly Population -- The Expectation of a Treatment Model: A framework for adherence and Effectiveness -- Pharmacoepidemiology and pharmacovigilance for safety and efficacy in older people -- Defining patient centric drug product design and its impact on improving safety and effectiveness -- Dosing considerations in older adults -- Oral Drug Product Use in the Elderly Patient Population -- Drug product development for older adults – multiparticulate formulations -- Considerations for topical and transdermal drug delivery in older adults -- Injectable drug delivery for older patients -- Inhalation and Nasal Formulations -- Ophthalmic drug development and the elderly -- Developing drug administration devices for use by older patients -- Manufacturing Platforms for Patient-Centric Drug Products -- Novel Manufacturing Technologies for the Production of Patient-Centric Drug Products -- Prescribing to Older Adults -- Multimorbidity and Polypharmacy -- Vaccination in Older Adults -- Medication Reviews in Older Adults -- The Personalization of Drug therapy for Elderly patients -- Importance of Clinical Nutrition in Therapy to Older Adults -- Managing drug therapy of older patients in primary and secondary care -- Medication adherence and monitoring -- Medication compounding in the provision of drug therapy -- Geriatric Pharmacotherapy: Optimisation through integrated approach in the hospital setting -- European Medicines Agency (EMA): Regulatory perspectives on geriatric medicines -- Views on the Therapeutic Needs of Older Adults -- Future Perspectives in drug therapy of older people -- Opportunities in drug product development in an aging population.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Geriatrics.
|
| 650 |
1 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 650 |
2 |
4 |
|a Geriatrics/Gerontology.
|
| 700 |
1 |
|
|a Stegemann, Sven.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|